EGFR and non-small cell lung carcinoma: In particular, the EMT transcriptional regulator ZEB1 has been demonstrated to reduce E-cadherin and increase vimentin in multiple EGFR-mutated NSCLC cells, thereby conferring resistance to EGFR-TKIs [36].